2nd Data Monitoring Committees Conference

Venue: The Fairmont San Francisco

Location: San Francisco, California, United States

Event Date/Time: Oct 15, 2007 End Date/Time: Oct 16, 2007
Report as Spam


The industry has seen an increase in the usage of Data Monitoring Committees (a.k.a. Data Safety Monitoring Boards) to gain independent usage of DMCs has no doubt in part resulted from increased concerns for patient safety after the removal of several unsafe drugs from the market lead to questionable clinical trial conduct and possible submission of inaccurate clinical data on safety.

DMCs offer an opportunity for a team of experts, independent from the trial sponsor, to examine the interim clinical data and make unbiased recommendations for the continuation, alteration and termination of the trial. Incorporating DMCs into trial design and conduct adds additional protection against proceeding with an unsafe product or futile trial design which mitigates risk to subjects, optimizes resource utilization for the sponsor by reassuring study integrity and protects the public from access to unsafe products.

Please don't hesitate to contact me if you have any questions. I look forward to seeing you in October.


950 Mason Street
United States